Deciphering the late steps of rifamycin biosynthesis

Rifamycin-derived drugs, including rifampin, rifabutin, rifapentine, and rifaximin, have long been used as first-line therapies for the treatment of tuberculosis and other deadly infections. However, the late steps leading to the biosynthesis of the industrially important rifamycin SV and B remain l...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nat Commun
Egile Nagusiak: Qi, Feifei, Lei, Chao, Li, Fengwei, Zhang, Xingwang, Wang, Jin, Zhang, Wei, Fan, Zhen, Li, Weichao, Tang, Gong-Li, Xiao, Youli, Zhao, Guoping, Li, Shengying
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6002545/
https://ncbi.nlm.nih.gov/pubmed/29904078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-04772-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak